Paraoxonase 1 192 and 55 polymorphisms in osteosarcoma

Molecular Biology Reports

Volumn 38, Issue 6, 2011, Pages 4181-4184

  Ergen, Arzu ^a   Kılıcoglu, Onder ^b   Ozger, Harzem ^b   Agachan, Bedia ^a   Isbir, Turgay ^c  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c YEDITEPE UNIVERSITY   (Turkey)

Author keywords

Osteosarcoma; Paraoxonase; Polymorphism; Risk

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1;

ADULT; ARTICLE; CATALYSIS; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MALE; OSTEOSARCOMA; POLYMERASE CHAIN REACTION; PON1 192 GENE; PON1 55 GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 80052433924     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0538-8     Document Type: Article

References (26)

1. Cejas P, Casado E, Belda-Iniesta C, De Castro J, Espinosa E, Redondo A, Sereno M, García-Cabezas MA, Vara JA, Domínguez- Cáceres A, Perona R, González-Barón M (2004) Implications of oxidative stress and cell membrane lipid peroxidation in human cancer (Spain). Cancer Causes Control 15:707-719. (Pubitemid 39066212)
2. Behrend L, Henderson G, Zwacka RM (2003) Reactive oxygen species in oncogenic transformation. Biochem Soc Trans 31: 1441-1444. (Pubitemid 38030996)
3. Costa LG, Cole TB, Jarvik GP, Furlong CE (2003) Functional genomics of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease and drug metabolism. Annu Rev Med 54:371-392. (Pubitemid 37386402)
4. Mackness MI, Mackness B, Durrington PN, Fogelman AM, Berliner J, Lusis AJ, Navab M, Shih D, Fonarow GC (1998) Paraoxonase and coronary heart disease. Curr Opin Lipidol 9(4): 319-324. (Pubitemid 28403351)
5. Shih DM, Gu L, Xia YR, Navab M, Li WF, Hama S, Castellani LW, Furlong CE, Costa LG, Fogelman AM, Lusis AJ (1998) Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 394:284-287. (Pubitemid 28335041)
6. Humbert R, Adler DA, Disteche CM, Omiecinski CJ, Furlong CE (1993) The molecular basis of the human serum paraoxonase polymorphisms. Nat Genet 3:73-76. (Pubitemid 23063292)
7. Adkins S, Gan KN, Mody M, LaDu BN (1993) Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes. Am J Hum Genet 53:598-608. (Pubitemid 23311330)
8. Ruiz J, Blanche H, James RW, Garin MC, Vaisse C, Charpentier G, Cohen N, Morabia A, Passa P, Froguel P (1995) Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet 346:869-872.
9. Akcay MN, Yilmaz I, Polat MF, Akcay G (2003) Serum paraoxonase levels in gastric cancer. Hepatogastroenterology 50(2): cclxxiii-cclxxv.
10. Akcay MN, Polat MF, Yilmaz I, Akcay G (2003) Serum paraoxonase levels in pancreatic cancer. Hepatogastroenterology 50(2):ccxxv-ccxxvii.
11. Elkiran ET, Mar N, Aygen B, Gursu F, Karaoglu A, Koca S (2007) Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population. BMC Cancer 7:48.
12. Stevens VL, Rodriguez C, Pavluck AL, Thun MJ, Calle EE (2006) Association of polymorphisms in the paraoxonase 1 gene with breast cancer incidence in the CPS-II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 15:1226-1228.
13. Gallicchio L, McSorley MA, Newschaffer CJ, Huang HY, Thuita LW, Hoffman SC, Helzlsouer KJ (2007) Body mass, polymorphisms in obesity-related genes, and the risk of developing breast cancer among women with benign breast disease. Cancer Detect Prev 31:95-101. (Pubitemid 46669815)
14. Antognelli C, Mearini L, Talesa VN, Giannantoni A, Mearini E (2005) Association of CYP17, GSTP1, and PON1 polymorphisms with the risk of prostate cancer. Prostate 63:240-251. (Pubitemid 40571058)
15. Lee CH, Lee KY, Choe KH, Hong YC, Kim YD, Kang JW, Kim H (2005) Effects of oxidative DNA damage induced by polycyclic aromatic hydrocarbons and genetic polymorphism of the paraoxonase-1 (PON1) gene on lung cancer. J Prev Med Pub Health 38:345-350.
16. Kerridge I, Lincz L, Scorgie F, Hickey D, Granter N, Spencer A (2002) Association between xenobiotic gene polymorphisms and non-Hodgkin's lymphoma risk. Br J Haematol 118:477-481. (Pubitemid 34994652)
17. Lincz LF, Kerridge I, Scorgie FE, Bailey M, Enno A, Spencer A (2004) Xenobiotic gene polymorphisms and susceptibility to multiple myeloma. Haematologica 89:628-629. (Pubitemid 38691261)
18. Miller SA, Dykes DD, Polesky HS (1988) Simples salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 16:1215.
19. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD 352 and haplotype maps. Bioinformatics 21:263-265. (Pubitemid 40202029)
20. Ames BN (1983) Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science 221:1256-1264.
21. Goldstein BD, Witz G (1990) Free radicals and carcinogenesis. Free Radic Res Commun 11:3-10.
22. Ferre' N, Camps J, Fernandez-Ballart J, Arija V, Murphy MH, Cerveco S, Biarnes E, Vilella E, Tous M, Joven J (2003) Regulation of serum paraoxonase activity by genetic, nutritional, and lifestyle factors in the general population. Clin Chem 49(9): 1491-1497. (Pubitemid 37011737)
23. Mackness B, Durrington PN, Mackness MI (1998) Human serum paraoxonase. Gen Pharmacol 31(3):329-336. (Pubitemid 28398854)
24. Stevens VL, Rodriguez C, Pavluck AL, Thun MJ, Calle EE (2006) Association of polymorphisms in the paraoxonase 1 gene with breast cancer incidence in the CPS-II nutrition cohort. Cancer Epidemiol Biomarkers Prev 15(6):1226-1228.
25. Rajaraman P, Hutchinson A, Rothman N, Black PM, Fine HA, Loeffler JS, Selker RG, Shapiro WR, Linet MS, Inskip PD (2008) Oxidative response gene polymorphisms and risk of adult brain tumors. Neuro Oncol 10:709-715.
26. Lurie G, Wilkens LR, Thompson PJ, McDuffie KE, Carney ME, Terada KY, Goodman MT (2008) Genetic polymorphisms in the paraoxonase 1 gene and risk of ovarian epithelial carcinoma. Cancer Epidemiol Biomarkers Prev 17(8):2070-2077.